- A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene. Narasaki, F., Oka, M., Fukuda, M., Nakano, R., Ikeda, K., Takatani, H., Terashi, K., Soda, H., Yano, O., Nakamura, T., Doyle, L.A., Tsuruo, T., Kohno, S. Cancer Chemother. Pharmacol. (1997)